In asthma-COPD overlap syndrome, patients with aspirin-exacerbated respiratory disease demonstrate dysregulated arachidonic acid metabolism through the 5-lipoxygenase pathway, leading to decreased PGE2 production and loss of control over leukotriene synthesis.